Literature DB >> 15113357

Liver and intestine transplantation.

Robert S Brown1, Sarah H Rush, Hugo R Rosen, Alan N Langnas, Goran B Klintmalm, Douglas W Hanto, Jeffrey D Punch.   

Abstract

The most significant development in liver transplantation in the USA over the past year was the full implementation of the MELD- and PELD-based allocation policy in March 2002, which shifted emphasis from waiting time within broad medical urgency status to prioritization by risk of waiting list death. The implementation of this system has led to a decrease in pretransplant mortality without increasing post-transplant mortality, despite a higher severity of illness at the time of transplant. The trend over the last few years of rapidly increasing numbers of adult living donor liver transplants was reversed in 2002 by a decline of more than 30% in the number of these procedures. In 2002, a greater percentage of women received livers from living donors (43%) than deceased donors (34%), possibly because of size considerations. From 1993 to 2001, the waiting list increased more than sixfold, from 2902 patients to 18,047 patients. For the first time since 1993, the waiting list size decreased in 2002, dropping 6% to 16,974 candidates. The percentage of temporarily inactive liver candidates also increased from 2001, thus the net decrease in the active waiting list for 2002 was 12%. This may reflect a trend toward less pre-emptive listing practices under MELD. Intestine transplantation remains a low-volume procedure limited to a few transplant centers and is still accompanied by significant pre- and post-transplantation risks. As this procedure matures, its application may increase to include recipients at an earlier stage of their disease with better likelihood of success.

Entities:  

Mesh:

Year:  2004        PMID: 15113357     DOI: 10.1111/j.1600-6135.2004.00400.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  8 in total

1.  Can we direct organ allocation based on predicted outcome? Hepatocellular carcinoma outside of UCSF criteria or retransplant?

Authors:  Caroline Rochon; Patricia Sheiner; Basant Mahadevappa; Ganesh Gunasekaran; Joyti Sharma; David C Wolf; Marcelo Facciuto
Journal:  Langenbecks Arch Surg       Date:  2012-01-28       Impact factor: 3.445

Review 2.  A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant population.

Authors:  C S Davis; J Gagermeier; D Dilling; C Alex; E Lowery; E J Kovacs; R B Love; P M Fisichella
Journal:  Clin Transplant       Date:  2010-03-19       Impact factor: 2.863

3.  Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States.

Authors:  John E Scarborough; Ricardo Pietrobon; Carlos E Marroquin; Janet E Tuttle-Newhall; Paul C Kuo; Bradley H Collins; Dev M Desai; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

4.  The diagnostic value of gastroesophageal reflux disease (GERD) symptoms and detection of pepsin and bile acids in bronchoalveolar lavage fluid and exhaled breath condensate for identifying lung transplantation patients with GERD-induced aspiration.

Authors:  Nicholas P Reder; Christopher S Davis; Elizabeth J Kovacs; P Marco Fisichella
Journal:  Surg Endosc       Date:  2014-01-11       Impact factor: 4.584

5.  Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation.

Authors:  John F Renz; Cindy Kin; Milan Kinkhabwala; Dominique Jan; Rhaghu Varadarajan; Michael Goldstein; Robert Brown; Jean C Emond
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

6.  A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry.

Authors:  Colleen Jay; Daniela Ladner; Edward Wang; Vadim Lyuksemburg; Raymond Kang; Yaojen Chang; Joseph Feinglass; Jane L Holl; Michael Abecassis; Anton I Skaro
Journal:  J Hepatol       Date:  2011-02-19       Impact factor: 25.083

7.  Laparoscopic fundoplication with or without pyloroplasty in patients with gastroesophageal reflux disease after lung transplantation: how I do it.

Authors:  Christopher S Davis; W Scott Jellish; P Marco Fisichella
Journal:  J Gastrointest Surg       Date:  2010-05-25       Impact factor: 3.452

8.  Donor surfactant protein D (SP-D) polymorphisms are associated with lung transplant outcome.

Authors:  B Aramini; C Kim; S Diangelo; E Petersen; D J Lederer; L Shah; H Robbins; J Floros; S M Arcasoy; J R Sonett; F D'Ovidio
Journal:  Am J Transplant       Date:  2013-07-10       Impact factor: 8.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.